Claudia Schlundt

Dr. Claudia Schlundt


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Bone
Verified
Journal Article
Closed access
CSClaudia Schlundt
Claudia Schlundt
TKThaqif El Khassawna
Thaqif El Khassawna
ASAlessandro Serra
Alessandro Serra
ADAnke Dienelt
Anke Dienelt
SWSebastian Wendler
Sebastian Wendler
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek

1 July 2014 in Bone
Verified
Journal Article
Closed access
IKIreen Könnecke
Ireen Könnecke
ASAlessandro Serra
Alessandro Serra
TKThaqif El Khassawna
Thaqif El Khassawna
CSClaudia Schlundt
Claudia Schlundt
HSHanna Schell
Hanna Schell
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek

1 January 2015 in Journal of Experimental Orthopaedics
Verified
Journal Article
Open access
PDF file
CSClaudia Schlundt
Claudia Schlundt
HSHanna Schell
Hanna Schell
Stuart B GoodmanStuart B Goodman
Stuart B Goodman
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic
GDGeorg Duda
Georg Duda
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek
We summarize research approaches and findings on bone healing and regeneration that were presented at a workshop at the 60th annual meeting of the Orthopedic Research Society (ORS) in New Orleans in 2014. The workshop was designed to discuss the role of inflammation in bone regeneration in the context of fundamental biology, and to develop therapeutic strategies that involve immune modulation. Delayed or non‐healing of bone is a major clinical problem, with around 10% of fracture patients suffering from unsatisfying healing outcomes. Inflammation is traditionally seen as a defense mechanism, but was recently found essential in supporting and modulating regenerative cascades. In bone healing, macrophages and T‐ and B‐cells interact with progenitor cells, bone forming osteoblasts and remodeling osteoclasts. Among the cells of the innate immunity, macrophages are promising candidates for targets in immune‐modulatory interventions that would overcome complications in bone healing and bone‐related diseases. Among the cells of the adaptive immune system, CD8+ T cells have been shown to have a negative impact on bone fracture healing outcome, whereas regulatory T cells could be promising candidates that have a positive, modulating effect on bone fracture healing. This workshop addressed recent advances and key challenges in this exciting interdisciplinary research field.

Verified
Journal Article
Open access
PDF file
JBJulia C. Berkmann
Julia C. Berkmann
AMAaron Xerach Herrera Martin
Aaron Xerach Herrera Martin
AEAgnes Ellinghaus
Agnes Ellinghaus
CSClaudia Schlundt
Claudia Schlundt
HSHanna Schell
Hanna Schell
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek
Local pH is stated to acidify after bone fracture. However, the time course and degree of acidification remain unknown. Whether the acidification pattern within a fracture hematoma is applicable to adjacent muscle hematoma or is exclusive to this regenerative tissue has not been studied to date. Thus, in this study, we aimed to unravel the extent and pattern of acidification in vivo during the early phase post musculoskeletal injury. Local pH changes after fracture and muscle trauma were measured simultaneously in two pre-clinical animal models (sheep/rats) immediately after and up to 48 h post injury. The rat fracture hematoma was further analyzed histologically and metabolomically. In vivo pH measurements in bone and muscle hematoma revealed a local acidification in both animal models, yielding mean pH values in rats of 6.69 and 6.89, with pronounced intra- and inter-individual differences. The metabolomic analysis of the hematomas indicated a link between reduction in tricarboxylic acid cycle activity and pH, thus, metabolic activity within the injured tissues could be causative for the different pH values. The significant acidification within the early musculoskeletal hematoma could enable the employment of the pH for novel, sought-after treatments that allow for spatially and temporally controlled drug release.

Verified
Journal Article
Open access
PDF file
CSConstanze S. Schwarz
Constanze S. Schwarz
CBChristian H. Bucher
Christian H. Bucher
CSClaudia Schlundt
Claudia Schlundt
SMSarah Mertlitz
Sarah Mertlitz
KRKatarina Riesner
Katarina Riesner
INIl-Kang Na
Il-Kang Na
The interaction of hematopoietic cells and the bone microenvironment to maintain bone homeostasis is increasingly appreciated. We hypothesized that the transfer of allogeneic T lymphocytes has extensive effects on bone biology and investigated trabecular and cortical bone structures, the osteoblast reconstitution, and the bone vasculature in experimental hematopoietic stem cell transplantations (HSCT). Allogeneic or syngeneic hematopoietic stem cells (HSC) and allogeneic T lymphocytes were isolated and transferred in a murine model. After 20, 40, and 60 days, bone structures were visualized using microCT and histology. Immune cells were monitored using flow cytometry and bone vessels, bone cells and immune cells were fluorescently stained and visualized. Remodeling of the bone substance, the bone vasculature and bone cell subsets were found to occur as early as day +20 after allogeneic HSCT (including allogeneic T lymphocytes) but not after syngeneic HSCT. We discovered that allogeneic HSCT (including allogeneic T lymphocytes) results in a transient increase of trabecular bone number and bone vessel density. This was paralleled by a cortical thinning as well as disruptive osteoblast lining and loss of B lymphocytes. In summary, our data demonstrate that the adoptive transfer of allogeneic HSCs and allogeneic T lymphocytes can induce profound structural and spatial changes of bone tissue homeostasis as well as bone marrow cell composition, underlining the importance of the adaptive immune system for maintaining a balanced bone biology.